KROS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $11.36

Market Cap (MRQ) $225M

P/E (TTM) -3.5

EPS (TTM) $-3.22

Revenue (TTM) $15M

ROE (TTM) -17.2%

52W Range $10–$23

KROS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue$244M

2019-12-31 → 2025-12-31

EPS$2.30

2020-12-31 → 2025-12-31

Free Cash Flow$106M

2020-12-31 → 2025-12-31

Net margin-572.1%

2021-12-31 → 2025-12-31

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	KROS	5Y avg	Peer Median	Verdict
P/E (TTM)	-3.55Y avg ≈-7.3	≈-7.3	·	·
P/S (TTM)	15.55Y avg ≈2818.5	≈2818.5	16.2	Fair value
P/B (MRQ)	0.95Y avg ≈3.4	≈3.4	2.1	Undervalued
Price / FCF (TTM)	-4.65Y avg ≈-10.2	≈-10.2	·	·
Price / Cash Flow (TTM)	-4.75Y avg ≈-10.4	≈-10.4	·	·
Price / Tangible Book	0.75Y avg ≈3.4	≈3.4	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	KROS	5Y avg	Peer Median	Verdict
Operating Margin (TTM)	-698.0%5Y avg ≈-29683.9%	≈-29683.9%	-734.7%	Weak
EBITDA Margin	27.7%5Y avg ≈-29683.9%	≈-29683.9%	-734.7%	Weak
Pretax Margin (TTM)	-592.3%5Y avg ≈-26708.2%	≈-26708.2%	-840.0%	Weak
Net Profit Margin (TTM)	-572.1%5Y avg ≈-26713.3%	≈-26713.3%	-692.5%	Weak
ROA (TTM)	-15.9%5Y avg ≈-24.9%	≈-24.9%	-36.6%	Top tier
ROE (TTM)	-17.2%5Y avg ≈-26.2%	≈-26.2%	-35.5%	Top tier
ROIC	21.1%5Y avg ≈-26.5%	≈-26.5%	21.1%	In line

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	5Y trend	KROS	5Y avg	Peer Median	Verdict
Current Ratio (MRQ)		22.05Y avg ≈17.9	≈17.9	5.4	Strong liquidity
Quick Ratio		14.35Y avg ≈17.2	≈17.2	5.1	Strong liquidity

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	KROS	5Y avg	Peer Median	Verdict
EPS (Diluted)	$2.305Y avg ≈$-2.91	≈$-2.91	·	·
Revenue / Share	$6.445Y avg ≈$1.48	≈$1.48	·	·
Cash Flow / Share	$2.845Y avg ≈$-2.22	≈$-2.22	·	·
Cash / Share	$14.715Y avg ≈$11.73	≈$11.73	·	·

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric	KROS	5Y avg	Peer Median	Verdict
Asset Turnover	0.55Y avg ≈0.1	≈0.1	0.1	Top tier
Receivables Turnover	77.35Y avg ≈16.8	≈16.8	·	·
Revenue / Employee	≈$2.7M	·	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise 270.2%

Next Report Nov 03, 2026

Period	Report	EPS Actual	EPS Est	Surprise
June 30, 2026	Aug 12, 2026	$-1.45	$-1.37	-6.1%
March 31, 2026	May 14, 2026	$-1.21	$-1.04	-16.0%
Dec. 31, 2025		$-0.86	$-0.64	-34.1%
Sept. 30, 2025		$-0.18	$-1.07	83.1%
June 30, 2025		$-0.76	$-1.15	34.2%
March 31, 2025		$3.62	$-0.25	1560.3%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 14

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue	$244M	$0	$151.0K	$0	$20M	$0	$10M
R&D Expense	$130M	$174M	$135M	$87M	$55M	$34M	$17M
SG&A Expense	$47M	$41M	$35M	$28M	$21M	$13M	$3M
Operating Expenses	$176M	$214M	$170M	$115M	$76M	$47M	$21M
Operating Income	$68M	$-211M	$-170M	$-115M	$-56M	$-47M	$-11M
Other Non-op	$-539.0K	$-954.0K	$-206.0K	$-613.0K	$-383.0K	$160.0K	$241.0K
Pretax Income	$92M	$-187M	$-153M	$-105M	$-57M	$-46M	$-12M
Income Tax	$5M	$300.0K	$0	$0	$2M	$-172.0K	$0
Net Income	$87M	$-187M	$-153M	$-105M	$-59M	$-45M	$-12M
EPS (Basic)	$2.34	$-5.00	$-5.20	$-4.15	$-2.52	$-2.93	·
EPS (Diluted)	$2.30	$-5.00	$-5.20	$-4.15	$-2.52	$-2.93	·
Shares (Basic)	37,221,211	37,437,652	29,447,119	25,241,030	23,333,914	15,506,397	·
Shares (Diluted)	37,859,106	37,437,652	29,447,119	25,241,030	23,333,914	15,506,397	·
EBITDA	$68M	$-211M	$-170M	$-115M	$-56M	$-47M	·

Balance Sheet 23

Metric	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$287M	$560M	$331M	$279M	$230M	$266M	$7M
Receivables	$4M	$3M	$143.0K	$0	$18M	$0	·
Prepaid Expense	$22M	$26M	$16M	$7M	$3M	$2M	$381.0K
Other Current Assets	$2M	$1M	$1M	$276.0K	$210.0K	$160.0K	$215.0K
Current Assets	$315M	$589M	$347M	$286M	$251M	$268M	$9M
PP&E (Net)	$4M	$4M	$4M	$2M	$1M	$724.0K	$708.0K
PP&E (Gross)	$9M	$7M	$6M	$3M	$2M	$1M	$1M
Accum. Depreciation	$4M	$3M	$2M	$1M	$846.0K	$721.0K	$453.0K
Other Non-current Assets	$0	$2M	$2M	$2M	$82.0K	$0	·
Total Assets	$338M	$616M	$370M	$307M	$255M	$269M	$11M
Accounts Payable	$2M	$5M	$5M	$3M	$4M	$2M	$2M
Accrued Liabilities	$16M	$21M	$18M	$13M	$7M	$5M	$2M
Current Liabilities	$20M	$27M	$24M	$17M	$12M	$7M	$4M
Capital Leases	$14M	$17M	$13M	$13M	$231.0K	$476.0K	$899.0K
Other Non-current Liabilities	·	·	·	·	$0	$62.0K	$119.0K
Total Liabilities	$35M	$44M	$38M	$29M	$12M	$8M	$10M
Common Stock	$4.0K	$4.0K	$3.0K	$2.0K	$2.0K	$2.0K	$1.0K
Paid-in Capital	$1.17B	$1.14B	$714M	$506M	$367M	$327M	$203.0K
Retained Earnings	$-482M	$-569M	$-381M	$-228M	$-124M	$-65M	$-20M
Treasury Stock	$385M	$0	·	·	·	·	·
Stockholders' Equity	$303M	$572M	$332M	$277M	$243M	$262M	$-19M
Liabilities + Equity	$338M	$616M	$370M	$307M	$255M	$269M	$11M
Shares Outstanding	19,543,706	40,554,705	31,841,084	27,543,453	23,974,834	23,192,866	2,429,705

Cash Flow 12

Metric	2025	2024	2023	2022	2021	2020	2019
Stock-based Comp	$29M	$35M	$29M	$19M	$12M	$4M	$59.0K
Deferred Tax	$0	$0	$0	$0	$0	$0	$0
Operating Cash Flow	$108M	$-161M	$-125M	$-70M	$-62M	$-37M	$-16M
CapEx	$2M	$2M	$2M	$1M	$1M	$294.0K	$271.0K
Investing Cash Flow	$-2M	$-2M	$-2M	$-1M	$-1M	$-294.0K	$-271.0K
Stock Issued	·	·	·	·	·	$141M	$0
Stock Repurchased	$375M	$0	·	·	·	·	·
Net Stock Activity	$-375M	·	·	·	·	$141M	·
Financing Cash Flow	$-378M	$392M	$179M	$120M	$29M	$296M	$14.0K
Net Change in Cash	$-273M	$229M	$52M	$49M	$-35M	$259M	$-16M
Taxes Paid	$7M	$0	·	·	·	$0	$256.0K
Free Cash Flow	$106M	$-163M	$-127M	$-71M	$-63M	$-37M	·

Profitability 7

Metric	2025	2024	2023	2022	2021	2020	2019
Operating Margin	27.7%	-5939.0%	-112543.7%	·	-280.5%	·	·
Net Margin	35.7%	-5277.6%	-101319.2%	·	-292.3%	·	·
Pretax Margin	37.7%	-5269.1%	-101319.2%	·	-282.2%	·	·
EBITDA Margin	27.7%	-5939.0%	-112543.7%	·	-280.5%	·	·
ROA	18.2%	-38.0%	-45.2%	-37.2%	-22.4%	-32.4%	·
ROE	17.2%	-33.9%	-48.7%	-40.4%	-25.4%	-23.1%	·
ROIC	21.1%	-37.0%	-51.1%	-41.4%	-24.0%	-17.8%	·

Liquidity & Solvency 2

Metric	Trend	2025	2024	2023	2022	2021	2020	2019
Current Ratio		15.5	21.5	14.2	17.3	21.2	37.3	·
Quick Ratio		14.3	20.5	13.6	16.9	20.9	37.0	·

Efficiency 2

Metric	Trend	2025	2024	2023	2022	2021	2020	2019
Asset Turnover		0.5	0.0	0.0	0.0	0.1	0.0	·
Receivables Turnover		77.3	2.5	2.1	0.0	2.2	·	·

Per Share 5

Metric	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$15.51	$14.09	$10.43	$10.07	$10.14	$11.28	·
Revenue / Share	$6.44	$0.09	$0.01	$0.00	$0.86	·	·
Cash Flow / Share	$2.84	$-4.30	$-4.23	$-2.78	$-2.66	·	·
Cash / Share	$14.71	$13.81	$10.40	$10.13	$9.60	$11.46	·
EPS (TTM)	$2.30	$-5.00	$-5.20	$-4.15	$-2.52	$-2.93	·

Valuation (TTM) 10

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$244M	$0	$151.0K	$0	$20M	$0	·
Net Income TTM	$87M	$-187M	$-153M	$-105M	$-59M	$-45M	·
Market Cap	$398M	$642M	$1.27B	$1.32B	$1.40B	$1.64B	·
P/E	8.9	-3.2	-7.6	-11.6	-23.2	-24.1	·
P/S	1.6	·	8384.1	·	69.8	·	·
P/B	1.3	1.1	3.8	4.8	5.8	6.3	·
P / Tangible Book	1.3	1.1	3.8	4.8	5.8	6.3	·
P / Cash Flow	3.7	-4.0	-10.2	-18.9	-22.6	-44.3	·
P / FCF	3.8	-3.9	-10.0	-18.5	-22.2	-44.0	·
Earnings Yield	11.3%	-31.6%	-13.1%	-8.6%	-4.3%	-4.2%	·

Income Statement 14

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$0	$32.0K	$380.0K	$14M	$18M	$211M	$0	$0	$0	$0	$143.0K	$8.0K	$0	$0	$0	$0
R&D Expense	$22M	$16M	$18M	$20M	$44M	$49M	$46M	$49M	$41M	$38M	$37M	$34M	$33M	$31M	$25M	$21M
SG&A Expense	$9M	$10M	$12M	$10M	$14M	$10M	$11M	$10M	$10M	$10M	$9M	$9M	$9M	$8M	$7M	$7M
Operating Expenses	$31M	$26M	$30M	$30M	$58M	$59M	$56M	$59M	$50M	$49M	$47M	$43M	$41M	$39M	$32M	$28M
Operating Income	$-31M	$-26M	$-29M	$-15M	$-40M	$152M	$-53M	$-59M	$-50M	$-48M	$-46M	$-43M	$-41M	$-39M	$-32M	$-28M
Other Non-op	$-60.0K	$-166.0K	$273.0K	$-253.0K	$-221.0K	$-338.0K	$-229.0K	$-92.0K	$-196.0K	$-437.0K	$56.0K	$-67.0K	$-155.0K	$-40.0K	$-1M	$762.0K
Pretax Income	$-29M	$-24M	$-25M	$-9M	$-33M	$158M	$-46M	$-53M	$-45M	$-43M	·	·	·	·	$-30M	$-24M
Income Tax	$0	$0	$-2M	$-1M	$-2M	$10M	$300.0K	$0	$0	$0	·	·	·	·	$0	$0
Net Income	$-29M	$-24M	$-23M	$-7M	$-31M	$148M	$-46M	$-53M	$-45M	$-43M	$-40M	$-39M	$-38M	$-36M	$-30M	$-24M
EPS (Basic)	$-1.45	$-1.21	$-0.38	$-0.18	$-0.76	$3.66	$-1.13	$-1.41	$-1.25	$-1.21	$-1.34	$-1.33	$-1.27	$-1.26	$-1.09	$-0.92
EPS (Diluted)	$-1.45	$-1.21	$-0.38	$-0.18	$-0.76	$3.62	$-1.13	$-1.41	$-1.25	$-1.21	$-1.34	$-1.33	$-1.27	$-1.26	$-1.09	$-0.92
Shares (Basic)	19,800,322	19,629,906	·	40,623,364	40,612,907	40,559,355	·	37,590,727	36,103,187	35,685,422	·	29,668,247	29,602,458	28,369,453	·	25,549,701
Shares (Diluted)	19,800,322	19,629,906	·	40,623,364	40,612,907	41,021,325	·	37,590,727	36,103,187	35,685,422	·	29,668,247	29,602,458	28,369,453	·	25,549,701
EBITDA	$-31M	$-26M	·	$-15M	$-40M	$152M	·	$-59M	$-50M	$-48M	·	$-43M	$-41M	$-39M	·	$-28M

Balance Sheet 22

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$258M	$281M	$287M	$693M	$690M	$721M	$560M	$531M	$406M	$442M	$331M	$288M	$322M	$351M	$279M	$239M
Receivables	$0	$400.0K	$4M	$3M	$16M	$17M	$3M	$388.0K	$4.0K	$226.0K	$143.0K	·	·	·	·	$0
Prepaid Expense	$7M	$7M	$22M	$22M	$27M	$22M	$26M	$21M	$27M	$20M	$16M	$17M	$12M	$11M	·	$6M
Other Current Assets	$760.0K	$1M	$2M	$3M	$3M	$3M	$1M	$1M	$582.0K	$616.0K	$1M	$319.0K	$376.0K	$515.0K	·	$745.0K
Current Assets	$267M	$291M	$315M	$719M	$733M	$760M	$589M	$552M	$433M	$463M	$347M	$304M	$334M	$362M	·	$246M
PP&E (Net)	$4M	$4M	$4M	$5M	$5M	$4M	$4M	$4M	$4M	$4M	$4M	$3M	$3M	$3M	·	$2M
PP&E (Gross)	·	·	$9M	·	·	·	$7M	·	·	·	$6M	·	·	·	·	·
Accum. Depreciation	·	·	$4M	·	·	·	$3M	·	·	·	$2M	·	·	·	·	·
Other Non-current Assets	·	·	$0	$0	$0	$463.0K	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	·	$3M
Total Assets	$288M	$312M	$338M	$743M	$757M	$785M	$616M	$579M	$455M	$486M	$370M	$326M	$356M	$384M	·	$253M
Accounts Payable	$2M	$1M	$2M	$2M	$5M	$7M	$5M	$5M	$7M	$5M	$5M	$4M	$4M	$5M	·	$3M
Accrued Liabilities	$8M	$9M	$16M	$15M	$20M	$17M	$21M	$22M	$14M	$13M	$18M	$12M	$12M	$11M	·	$8M
Current Liabilities	$12M	$13M	$20M	$24M	$35M	$39M	$27M	$29M	$21M	$19M	$24M	$17M	$16M	$15M	·	$12M
Capital Leases	$13M	$14M	$14M	$15M	$16M	$16M	$17M	$17M	$13M	$13M	$13M	$14M	$14M	$14M	·	$0
Total Liabilities	$25M	$27M	$35M	$39M	$50M	$56M	$44M	$46M	$34M	$32M	$38M	$30M	$30M	$29M	·	$12M
Common Stock	$4.0K	$4.0K	$4.0K	$4.0K	$4.0K	$4.0K	$4.0K	$4.0K	$3.0K	$3.0K	$3.0K	$3.0K	$3.0K	$3.0K	·	$2.0K
Paid-in Capital	$1.18B	$1.18B	$1.17B	$1.16B	$1.16B	$1.15B	$1.14B	$1.06B	$891M	$878M	$714M	$637M	$628M	$619M	·	$440M
Retained Earnings	$-534M	$-505M	$-482M	$-458M	$-451M	$-420M	$-569M	$-523M	$-470M	$-425M	$-381M	$-341M	$-302M	$-264M	·	$-199M
Treasury Stock	$385M	$385M	$385M	·	·	·	$0	·	·	·	·	·	·	·	·	·
Stockholders' Equity	$262M	$286M	$303M	$704M	$707M	$729M	$572M	$533M	$421M	$454M	$332M	$296M	$326M	$355M	$277M	$241M
Liabilities + Equity	$288M	$312M	$338M	$743M	$757M	$785M	$616M	$579M	$455M	$486M	$370M	$326M	$356M	$384M	·	$253M
Shares Outstanding	19,827,188	19,732,837	19,543,706	40,632,164	40,615,414	40,562,047	40,554,705	39,258,476	36,169,558	36,067,786	31,841,084	29,679,143	29,661,005	29,548,649	·	26,077,204

Cash Flow 9

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Stock-based Comp	$5M	$6M	$7M	$4M	$9M	$9M	$9M	$9M	$9M	$8M	$7M	$9M	$7M	$6M	$5M	$5M
Operating Cash Flow	$-20M	$-4M	$-27M	$3M	$-30M	$161M	$-46M	$-30M	$-40M	$-45M	$-25M	$-34M	$-31M	$-34M	$-21M	$-25M
CapEx	$155.0K	$73.0K	$134.0K	$132.0K	$720.0K	$565.0K	$289.0K	$386.0K	$310.0K	$946.0K	$541.0K	$550.0K	$311.0K	$1M	$351.0K	$176.0K
Investing Cash Flow	$-155.0K	$-73.0K	$-134.0K	$-132.0K	$-720.0K	$-565.0K	$-289.0K	$-386.0K	$-310.0K	$-946.0K	$-541.0K	$-550.0K	$-311.0K	$-1M	$-351.0K	$-176.0K
Stock Issued	·	·	·	·	·	·	·	·	·	$151M	·	$0	$0	$107M	·	$48M
Net Stock Activity	·	·	·	·	·	·	·	·	·	$151M	·	·	·	$107M	·	·
Financing Cash Flow	$-3M	$-2M	$-379M	$140.0K	$17.0K	$4.0K	$76M	$156M	$4M	$157M	$69M	$284.0K	$2M	$108M	$61M	$49M
Net Change in Cash	$-24M	$-6M	$-406M	$3M	$-30M	$161M	$29M	$125M	$-37M	$111M	$43M	$-34M	$-29M	$72M	$40M	$24M
Free Cash Flow	·	$-4M	·	·	·	$161M	·	·	·	$-46M	·	·	·	$-35M	·	·

Profitability 7

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	·	-80865.6%	·	-108.9%	-219.2%	72.0%	·	-15117.8%	-136321.6%	-58413.3%	·	-541000.0%	·	·	·	·
Net Margin	·	-74087.5%	·	-51.5%	-169.0%	70.3%	·	-13648.4%	-122316.2%	-51944.6%	·	-493000.0%	·	·	·	·
Pretax Margin	·	-74087.5%	·	-61.6%	-181.2%	75.0%	·	·	·	·	·	·	·	·	·	·
EBITDA Margin	·	-80865.6%	·	-108.9%	-219.2%	72.0%	·	-15117.8%	-136321.6%	-58413.3%	·	-541000.0%	·	·	·	·
ROA	-5.5%	-4.3%	·	-1.1%	-5.1%	23.4%	·	-11.7%	-11.2%	-9.9%	·	-13.6%	-12.9%	-11.6%	·	-9.7%
ROE	-5.9%	-4.7%	·	-1.2%	-5.4%	25.1%	·	-12.8%	-12.1%	-10.7%	·	-14.7%	-14.0%	-12.4%	·	-10.2%
ROIC	-11.8%	-9.1%	·	-1.8%	-5.2%	19.5%	·	·	·	·	·	·	·	·	·	-11.6%

Liquidity & Solvency 2

Metric	Trend	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		22.0	22.6	·	29.9	21.1	19.3	·	19.0	20.4	24.7	·	18.2	20.8	23.4	·	21.3
Quick Ratio		21.2	21.9	·	28.9	20.3	18.7	·	18.3	19.1	23.6	·	17.2	20.0	22.7	·	20.8

Efficiency 2

Metric	Trend	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.3	·	0.0	0.0	0.0	·	0.0	·	·	·	0.0
Receivables Turnover		0.0	0.0	·	7.3	2.3	24.1	·	2.0	18.5	0.7	·	·	·	·	·	·

Per Share 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$13.23	$14.47	·	$17.32	$17.40	$17.97	·	$13.57	$11.64	$12.59	·	$9.97	$11.00	$12.01	·	$9.24
Revenue / Share	$0.00	$0.00	·	$0.35	$0.45	$5.15	·	$0.01	$0.00	$0.00	·	$0.00	·	·	·	$0.00
Cash Flow / Share	·	$-0.18	·	·	·	$3.93	·	·	·	$-1.25	·	·	·	$-1.21	·	·
Cash / Share	$12.99	$14.27	·	$17.07	$16.99	$17.76	·	$13.52	$11.22	$12.27	·	$9.70	$10.86	$11.89	·	$9.18
EPS (TTM)	$-3.22	$-2.53	·	$1.55	$0.32	$-0.17	·	$-5.21	$-5.13	$-5.15	·	$-4.95	$-4.54	$-4.40	·	$-3.36

Valuation (TTM) 9

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$15M	$33M	·	$243M	$229M	$211M	·	$143.0K	$151.0K	$151.0K	·	$8.0K	$0	$0	·	·
Net Income TTM	$-83M	$-85M	·	$64M	$19M	$4M	·	$-182M	$-168M	$-160M	·	$-142M	$-127M	$-116M	·	$-82M
Market Cap	$212M	$218M	·	$643M	$542M	$413M	·	$2.28B	$1.65B	$2.39B	·	$946M	$1.19B	$1.26B	·	$981M
P/E	-3.3	-4.4	·	10.2	41.7	-59.9	·	-11.1	-8.9	-12.9	·	-6.4	-8.9	-9.7	·	-11.2
P/S	14.6	6.7	·	2.6	2.4	2.0	·	15942.2	10946.7	15812.5	·	118271.4	·	·	·	·
P/B	0.8	0.8	·	0.9	0.8	0.6	·	4.3	3.9	5.3	·	3.2	3.7	3.6	·	4.1
P / Tangible Book	0.8	0.8	·	0.9	0.8	0.6	·	4.3	3.9	5.3	·	3.2	3.7	3.6	·	4.1
P / Cash Flow	·	-61.7	·	·	·	2.6	·	·	·	-53.6	·	·	·	-36.9	·	·
Earnings Yield	-30.1%	-22.9%	·	9.8%	2.4%	-1.7%	·	-9.0%	-11.2%	-7.8%	·	-15.5%	-11.3%	-10.3%	·	-8.9%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$244M	$0	$151.0K	$0	$20M
Operating Margin %	27.7%	-5939.0%	-112543.7%	·	-280.5%
Net Income	$87M	$-187M	$-153M	$-105M	$-59M
Diluted EPS	$2.30	$-5.00	$-5.20	$-4.15	$-2.52

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Current Ratio	15.5	21.5	14.2	17.3	21.2
Quick Ratio	14.3	20.5	13.6	16.9	20.9

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	$106M	$-163M	$-127M	$-71M	$-63M

Institutional owners (13F) 146 filers · $234.1M total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 146

Value held $234.1M

New positions 16

Exited positions 29

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
16 (-14 vs prior Q)	29 (-7 vs prior Q)	46 (+1 vs prior Q)	49 (-8 vs prior Q)	-122K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
VANGUARD GROUP INC	$31,056,228	1,525,355	13.27%	Shares
BlackRock, Inc.	$29,898,120	2,794,217	12.77%	Shares
Nantahala Capital Management, LLC	$15,091,483	1,410,419	6.45%	Shares
AQR CAPITAL MANAGEMENT LLC	$10,356,092	967,859	4.42%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$8,919,477	833,596	3.81%	Shares
ORBIMED ADVISORS LLC	$8,122,959	759,155	3.47%	Shares
FEDERATED HERMES, INC.	$7,494,569	700,427	3.20%	Shares
VANGUARD PORTFOLIO MANAGEMENT LLC	$6,983,195	652,635	2.98%	Shares
MACKENZIE FINANCIAL CORP	$6,724,287	628,438	2.87%	Shares
Madison Avenue Partners, LP	$6,704,438	626,583	2.86%	Shares
Qube Research & Technologies Ltd	$6,514,556	608,837	2.78%	Shares
JACOBS LEVY EQUITY MANAGEMENT, INC	$6,478,262	605,445	2.77%	Shares
STATE STREET CORP	$5,790,765	541,193	2.47%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$5,467,568	510,841	2.34%	Shares
DIMENSIONAL FUND ADVISORS LP	$4,928,290	460,541	2.11%	Shares
CITADEL ADVISORS LLC	$4,238,249	396,098	1.81%	Shares
RENAISSANCE TECHNOLOGIES LLC	$3,842,220	359,086	1.64%	Shares
TWO SIGMA ADVISERS, LP	$3,497,848	171,800	1.49%	Shares
D. E. Shaw & Co., Inc.	$2,861,822	267,460	1.22%	Shares
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$2,835,682	265,017	1.21%	Shares
Nuveen, LLC	$2,650,989	247,756	1.13%	Shares
ADAR1 Capital Management, LLC	$2,640,953	246,818	1.13%	Shares
TWO SIGMA INVESTMENTS, LP	$2,639,144	246,649	1.13%	Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$2,494,973	233,175	1.07%	Shares
MILLENNIUM MANAGEMENT LLC	$1,977,595	184,822	0.84%	Shares
Cubist Systematic Strategies, LLC	$1,922,605	121,530	0.82%	Shares
GOLDMAN SACHS GROUP INC	$1,902,953	177,846	0.81%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1,698,218	158,712	0.73%	Shares
Man Group plc	$1,664,289	155,541	0.71%	Shares
WELLS FARGO & COMPANY/MN	$1,663,636	155,480	0.71%	Shares
NORTHERN TRUST CORP	$1,646,121	153,843	0.70%	Shares
Empowered Funds, LLC	$1,521,016	142,151	0.65%	Shares
UBS Group AG	$1,476,461	137,987	0.63%	Shares
VANGUARD FIDUCIARY TRUST CO	$1,405,060	131,314	0.60%	Shares
Connor, Clark & Lunn Investment Management Ltd.	$1,368,370	127,885	0.58%	Shares
O'SHAUGHNESSY ASSET MANAGEMENT, LLC	$1,352,255	126,379	0.58%	Shares
JANE STREET GROUP, LLC	$1,233,357	115,267	0.53%	Shares
Nebula Research & Development LLC	$1,206,920	90,406	0.52%	Shares
Bank of New York Mellon Corp	$1,105,726	103,339	0.47%	Shares
AMERIPRISE FINANCIAL INC	$1,084,360	101,342	0.46%	Shares
AMERICAN CENTURY COMPANIES INC	$906,076	84,680	0.39%	Shares
LOS ANGELES CAPITAL MANAGEMENT LLC	$902,781	84,372	0.39%	Shares
MORGAN STANLEY	$848,366	79,286	0.36%	Shares
Invesco Ltd.	$765,724	71,563	0.33%	Shares
HSBC HOLDINGS PLC	$761,494	69,926	0.33%	Shares
MARTINGALE ASSET MANAGEMENT L P	$725,418	67,796	0.31%	Shares
PRINCIPAL FINANCIAL GROUP INC	$682,735	63,807	0.29%	Shares
RBF Capital, LLC	$671,960	62,800	0.29%	Shares
AlphaQuest LLC	$653,352	32,090	0.28%	Shares
Russell Investments Group, Ltd.	$651,546	60,892	0.28%	Shares

Show all 146 institutional owners →

Activists & 5%+ owners 4 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer	Filed	Stake	Status	Purpose	Filing
Pontifax Management 4 GP (2015) Ltd., Pontifax (Israel) IV, L.P., Pontifax (Cayman) IV, L.P., Pontifax (China) IV, L.P., Pontifax Late Stage Fund L.P., Pontifax Late Stage GP Ltd. ×3 filings	Oct. 16, 2025	0.00%	Amendment	·	SEC
ADAR1 Capital Management, LLC, ADAR1 Capital Management GP, LLC, Daniel Schneeberger ×6 filings	Oct. 15, 2025	0.00%	Amendment	·	SEC
OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC, OrbiMed Capital LLC ×4 filings	Dec. 13, 2023	·	Initial filing	·	SEC
Arkin Bio Ventures Limited Partnership, Arkin Bio Venture Partners Ltd., Moshe Arkin, Alon Lazarus ×3 filings	Dec. 17, 2020	·	Initial filing	Board campaign	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 21 insiders · 10 officers · 12 directors

19

Insider	Role	Last activity	Shares owned	Buys 12m	Sells 12m	Net 12m
Jasbir Seehra	CHIEF EXECUTIVE OFFICER	April 2, 2026 M	440,708	0	1	$-113,433
Keith Regnante	CHIEF FINANCIAL OFFICER	Feb. 24, 2026 A	39,261	0	1	$-77,483
Christopher Rovaldi	Chief Operating Officer	Feb. 18, 2025 A	60,000	0	0	$0
Annita Tanini	Corp. Controller & VP, Finance	Aug. 18, 2026 S	45,144	0	1	$-12,595
Esther Cho	Chief Legal Officer	Aug. 18, 2026 S	35,770	0	2	$-123,732
Lorena Raquel Lerner	Chief Scientific Officer	Aug. 18, 2026 S	27,559	0	2	$-100,039
Yung H. Chyung	Chief Medical Officer	Feb. 18, 2025 A	44,000	0	0	$0
Simon Peter Cooper	CHIEF MEDICAL OFFICER	Feb. 13, 2024 A	·	0	0	$0
Jennifer Lachey	Chief Scientific Officer	July 15, 2022 M	95,100	0	0	$0
Claudia Ordonez	Chief Medical Officer	June 11, 2021 M	0	0	0	$0
Charles W. Newton	Director	Aug. 18, 2026 S	12,114	0	2	$-11,197
Jean Jacques Bienaime	Director	Aug. 17, 2026 P	19,592	6	0	$75,770
Anne Prener	Director	July 1, 2026 A	13,786	0	0	$0
Julius Knowles	Director	June 4, 2026 S	10,958	0	1	$-28,166
Nima Farzan	Director	June 4, 2026 S	9,767	0	1	$-28,166
Alpna Seth	Director	June 3, 2026 A	12,392	0	1	$-28,140
Mary Ann Gray	Director	June 3, 2026 A	12,392	0	0	$0
GORDON CARL L	Director	Nov. 21, 2025 D	45,057	0	0	$0
Ran Nussbaum	Director	June 4, 2025 A	5,250	0	0	$0
Tomer Kariv	Director	June 4, 2025 A	5,250	0	0	$0
Alon Lazarus	Director	April 13, 2020 C	2,013,102	0	0	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 23 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
IWC · iShares Trust	0.05%	63,056 SH	Sept. 11, 2026	Daily
OMFS · Invesco Exchange-Traded Self-Indexe…	0.03%	6,390 SH	Oct. 2, 2026	Daily
PRFZ · Invesco Exchange-Traded Fund Trust	0.02%	54,912 SH	Oct. 2, 2026	Daily
VFVA · VANGUARD WELLINGTON FUND	0.02%	17,295 SH	Aug. 19, 2026	Daily
IBBQ · Invesco Exchange-Traded Fund Trust …	0.02%	1,424 SH	Oct. 2, 2026	Daily
IBB · iShares Trust	0.01%	136,946 SH	Sept. 11, 2026	Daily
DFSV · Dimensional ETF Trust	0.01%	86,247 NS	July 31, 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0.01%	106,081 SH	Aug. 19, 2026	Daily
VTWV · VANGUARD SCOTTSDALE FUNDS	0.01%	16,122 SH	Aug. 19, 2026	Daily
IWM · iShares Trust	0.01%	466,203 SH	Sept. 11, 2026	Daily
RSSL · Global X Funds	0.01%	8,840 NS	July 31, 2026	N-PORT
DFAS · Dimensional ETF Trust	0.00%	49,988 NS	July 31, 2026	N-PORT
DXUV · Dimensional ETF Trust	0.00%	1,300 NS	July 31, 2026	N-PORT
DCOR · Dimensional ETF Trust	0.00%	2,135 NS	July 31, 2026	N-PORT
IWV · iShares Trust	0.00%	7,159 SH	Sept. 3, 2026	Daily
DFAU · Dimensional ETF Trust	0.00%	4,900 NS	July 31, 2026	N-PORT
DFAC · Dimensional ETF Trust	0.00%	20,827 NS	July 31, 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0.00%	220,854 SH	Aug. 19, 2026	Daily
VTI · VANGUARD INDEX FUNDS	0.00%	595,316 SH	Aug. 19, 2026	Daily
VTHR · VANGUARD SCOTTSDALE FUNDS	0.00%	980 SH	Aug. 19, 2026	Daily
VHT · VANGUARD WORLD FUND	0.00%	49,290 SH	Aug. 19, 2026	Daily
IWN · iShares Trust	·	173,481 SH	Sept. 11, 2026	Daily
SMLF · iShares Trust	·	105,118 SH	Sept. 11, 2026	Daily

KROS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 13 analysts BUY

Median target $19.00 +67.3%

3 23.1% Strong Buy

6 46.2% Buy

4 30.8% Hold

0 0.0% Sell

0 0.0% Strong Sell

12-Month Price Target

6 analysts · 2026-09-29

Mean target $19.83 +74.6%

← Below all targets Current price $11.36

Low$16.00 Mean$19.83 High$25.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
KROS	$398M	8.9	·	35.7%	17.2%	·
IVVD	$697M	-8.2	110.5%	-98.2%	-36.9%	·
LYEL	$654M	-1.9	-41.0%	-762355.6%	-100.3%	·
MGNX	$102M	-1.4	-0.31%	-49.9%	-87.0%	·
RNAC	$188M	-1.4	-92.8%	-4658.6%	202.4%	·
SION	$1.84B	-21.9	·	·	-23.4%	·
TRDA	$394M	-3.0	-87.9%	-565.5%	-41.9%	·
WHWK	$114M	-7.3	-72.5%	-288.3%	-13.4%	·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

KROS Keros Therapeutics, Inc. - common stock